MDL-107826A |
NSC-649890 |
L-86-8275 |
L-868275 |
ALVOCIDIB |
HL-275 |
HMR-1275 |
FLAVOPIRIDOL |
HMR-1274 |
L 86-8275 |
ALVOCIDIB FREEBASE |
HMR 1275 |
HL 275 |
2-(2-CHLOROPHENYL)-5,7-DIHYDROXY-8-[(3S,4R)-3-HYDROXY-1-METHYLPIPERIDIN-4-YL]-4H-CHROMEN-4-ONE |
HMR 1274 |
L 868275 |
(-)-CIS-5,7-DIHYDROXY-2-(2-CHLOROPHENYL)-8-(4-(3-HYDROXY-1-METHYL)PIPERIDINYL)-4H-1-BENZOPYRAN-4-ONE |
L86-8275 |
chembl:CHEMBL428690 |
drugbank:03496 |
chemidplus:146426-40-6 |
pubchem.compound:5287969 |
Drug Class | Kinase Inhibitors |
FDA Approval | not approved |
Drug Class | Small molecule |
Drug Indications | antineoplastic agent |
n/a |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
Novel drug target | Novel Target |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase 9 inhibitor |
Direct Interaction | yes |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase 6 inhibitor |
Direct Interaction | yes |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase 7 inhibitor |
Direct Interaction | yes |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
n/a |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
Novel drug target | Novel Target |
inhibitor (inhibitory) |
Mechanism of Interaction | Cyclin-dependent kinase 4 inhibitor |
Direct Interaction | yes |
Novel drug target | Novel Target |
n/a |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
Novel drug target | Novel Target |
inhibitor (inhibitory) |
Novel drug target | Novel Target |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
Mechanism of Interaction | Cyclin-dependent kinase 1 inhibitor |
inhibitor (inhibitory) |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
Novel drug target | Novel Target |
Mechanism of Interaction | Cyclin-dependent kinase 2 inhibitor |
inhibitor (inhibitory) |
Trial Name | flavopiridol, alvocidib, HMR-1275 |
Novel drug target | Novel Target |
HMR-1275 | Development Name |
FLAVOPIRIDOL | Development Name |
ALVOCIDIB | Generic Name |
Drug Class | Kinase Inhibitors |
Drug Indications | antineoplastic agent |
Drug Class | Small molecule |
FDA Approval | not approved |
CHEMBL428690 | ChEMBL Drug ID |
C1571 | NCI drug code |